Science and activities relating to the Detection, Assessment, Understanding, Prevention of adverse effects or any other drug-related problem.

The scope of Pharmacovigilance extends across various aspects of drug safety and ‎monitoring. It plays a crucial role in ensuring that medications remain safe and effective ‎throughout their lifecycle. It is the only way to protect the Patients and Consumers through its ‎reporting.

One National Pharmacovigilance Coordination Cente (NPvCC), Five Intermediary Centres (5-IPvCs) and 97 Peripheral Centers (97-PPvCs).

Documenting the Adverse Drug Reactions (ADR)

Capturing the Objectionable advertisements (OA)/ Misleading Advertisements (MLA).

Patient Safety is a healthcare discipline that emerged with the evolving complexity of healthcare systems and the resulting rise of patient harm in healthcare facilities.

Noxious and unintended, and which occurs at doses normally used in man for the prophylaxis, diagnosis or therapy of disease, or the modification of physiological function.

Any untoward medical occurrence that may present during treatment with a pharmaceutical product, but which does not necessarily have a causal relationship with this treatment.

Any event which causes death, permanent damage, birth defects, or requires prolonged hospitalization.

Any Health Care Professional including Doctors, Nurses, Pharmacists can report the ADRs. Patients can report through their Physician/ Medical Faculty Member.

Report as soon as you suspect that drug/ therapy has resulted in a negative, unintended effect.

The suspected ADRs can be reported to the designated structures of Peripheral Pharmacovigilance Centers (PPvCs) and Intermediary Pharmacovigilance Centers (IPvCs) available across the country.

Reporting ADRs helps improve patient safety, safeguard public health, and enhance drug ‎monitoring.‎

It helps to address the common misconception that natural medicines are always safe and to ensure that AYUSH medicines are used responsibly, especially when combined with other medications.

An objectionable advertisement refers to any promotional content that is misleading, deceptive to consumers. They not only have detrimental effects, but have a direct implication over health status of the consumer, and bring a bad reputation to the healthcare system. In India, the Drugs and Magic Remedies (Objectionable Advertisements) Act, 1954 regulates advertisements related to drugs and medical treatments to prevent false claims and protect public health.

Any advertisement or promotion through Television, Radio, or any other electronic media, Newspapers, Banners, Posters, Handbills, wall-writing etc. to misrepresent the nature, characteristics, qualities or geographic origin of goods, services or commercial activities to mislead the consumer could be broadly defined as a misleading advertisement.

Ayush Suraksha monitors and reports Objectionable advertisements (OA)/ Misleading Advertisements (MLAs) to relevant authorities for appropriate action.

Misleading Claims: Advertisements that falsely promise miraculous cures or exaggerated benefits.

Prohibited Diseases: Advertisements promoting treatments for conditions like cancer, diabetes, infertility etc. without scientific backing.

Magic Remedies: Advertisements endorsing talismans, mantras, or other unscientific methods for medical treatment.

Consumer Protection: The law ensures that advertisements do not exploit vulnerable individuals seeking medical solutions.

Anyone can report an OA or MLA, through the designated structures of Peripheral Pharmacovigilance Centers (PPvCs), Intermediary Pharmacovigilance Centers (IPvCs), and National Pharmacovigilance Coordination Centres (NPvCC).

There is a specific public complaint form that is also available on Portal.

Any individual can submit including the health care providers.

(a) directly or indirectly gives a false impression regarding the true character of the drug, or

(b) makes a false claim for the drug. or

(c) is otherwise false or misleading in any material particular